AR023794A1 - Antigeno asociado con tumores - Google Patents
Antigeno asociado con tumoresInfo
- Publication number
- AR023794A1 AR023794A1 ARP000102035A ARP000102035A AR023794A1 AR 023794 A1 AR023794 A1 AR 023794A1 AR P000102035 A ARP000102035 A AR P000102035A AR P000102035 A ARP000102035 A AR P000102035A AR 023794 A1 AR023794 A1 AR 023794A1
- Authority
- AR
- Argentina
- Prior art keywords
- tumors
- antigen associated
- encode
- well
- dna molecules
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19919225A DE19919225A1 (de) | 1999-04-28 | 1999-04-28 | Tumorassoziiertes Antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
AR023794A1 true AR023794A1 (es) | 2002-09-04 |
Family
ID=7906100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000102035A AR023794A1 (es) | 1999-04-28 | 2000-04-28 | Antigeno asociado con tumores |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1177288A1 (de) |
JP (1) | JP2004500024A (de) |
AR (1) | AR023794A1 (de) |
AU (1) | AU4553100A (de) |
CA (1) | CA2365278A1 (de) |
CO (1) | CO5300468A1 (de) |
DE (1) | DE19919225A1 (de) |
MX (1) | MXPA01010740A (de) |
WO (1) | WO2000066727A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005536439A (ja) * | 2001-09-18 | 2005-12-02 | ジェネンテック・インコーポレーテッド | 腫瘍の診断及び治療のための組成物と方法 |
WO2003063770A2 (en) | 2001-11-07 | 2003-08-07 | Mannkind Corporation | Expression vectors encoding epitopes of target-associated antigens and methods for their design |
JP2006238757A (ja) * | 2005-03-02 | 2006-09-14 | Eiken Chem Co Ltd | 癌を検出するためのマーカー |
DE102005041616B4 (de) * | 2005-09-01 | 2011-03-17 | Johannes-Gutenberg-Universität Mainz | Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und für diese kodierende Polynukleotide und deren Verwendungen |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998039448A2 (en) * | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 human secreted proteins |
CA2353603C (en) * | 1998-12-04 | 2010-08-03 | Henrick Clausen | Udp-n- acetyl glucosamine: galactose-.beta.1, 3-n- acetyl galactosamine- .alpha.-r/ n- acetyl glucosamine -.beta.1, 3-n- acetyl galactosamine- .alpha.-r (glcnac to galnac) .beta.1,6-n- acetyl glucosaminyl transferase, c2/4gnt |
-
1999
- 1999-04-28 DE DE19919225A patent/DE19919225A1/de not_active Ceased
-
2000
- 2000-04-19 CA CA002365278A patent/CA2365278A1/en not_active Abandoned
- 2000-04-19 WO PCT/EP2000/003552 patent/WO2000066727A1/de not_active Application Discontinuation
- 2000-04-19 EP EP00926997A patent/EP1177288A1/de not_active Withdrawn
- 2000-04-19 MX MXPA01010740A patent/MXPA01010740A/es unknown
- 2000-04-19 JP JP2000615751A patent/JP2004500024A/ja active Pending
- 2000-04-19 AU AU45531/00A patent/AU4553100A/en not_active Abandoned
- 2000-04-27 CO CO00030397A patent/CO5300468A1/es not_active Application Discontinuation
- 2000-04-28 AR ARP000102035A patent/AR023794A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA01010740A (es) | 2002-06-04 |
JP2004500024A (ja) | 2004-01-08 |
AU4553100A (en) | 2000-11-17 |
CA2365278A1 (en) | 2000-11-09 |
EP1177288A1 (de) | 2002-02-06 |
WO2000066727A9 (de) | 2002-09-12 |
CO5300468A1 (es) | 2003-07-31 |
WO2000066727A1 (de) | 2000-11-09 |
DE19919225A1 (de) | 2000-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120070T1 (el) | Μεθοδοi θεραπευτικης αγωγης με τη χρηση συζευγματων αντισωματος εναντι-erbb-μεϋτανσινοειδους | |
TW581808B (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
AR006250A1 (es) | Compuestos y metodos para la inmunoterapia e inmunodiagnostico del cancer prostatico | |
MXPA05008128A (es) | Peptidos derivados de survivina y uso de los mismos. | |
MY150237A (en) | Cripto blocking antibodies and uses thereof | |
IL163902A0 (en) | Antibodies against cancer antigen tmeff2 and uses thereof | |
CY1109468T1 (el) | Χρησεις ανταγωνιστων της il-23. σχετικα αντιδραστηρια | |
WO2004050707A3 (de) | Tumorspezifische erkennungsmoleküle | |
ZA200200097B (en) | Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof. | |
CR8231A (es) | Anticuerpos rg1 y uso de los mismos | |
AU2003242305A1 (en) | Hla-a24-restricted cancer antigen peptide | |
TR200001646T2 (tr) | Bir salgılanmış meme kanseri proteini olan mamaglobin. | |
CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
BR112021025699A2 (pt) | Anticorpos anti-mesotelina e imunoconjugados dos mesmos | |
MXPA05008794A (es) | Antigeno de glicoproteina sima135 expresado en celulas tumorales humanas metastasicas. | |
AU8727201A (en) | Genes involved in intestinal inflammatory diseases and use thereof | |
UY26266A1 (es) | Antigeno asociado con tumores (r11) ley 17164 | |
DE60315827D1 (de) | Verbesserte polysaccharid- und glykokonjugat-vakzine | |
DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
MY141459A (en) | Recombinant anti-idiotypic antibodies | |
AR024114A1 (es) | Antigeno (c42) asociado a tumores | |
DK1290160T3 (da) | Humane Pellino-polypeptider | |
AR023794A1 (es) | Antigeno asociado con tumores | |
WO2005099361A3 (en) | MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN |